| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Byam Rebecca is a Chief Financial Officer at HCW Biologics Inc.. Recent SEC Form 4 filings include 13 buys and 0 sells.
Estimated insider holdings value: $14K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 | HCWB Hcw Biologics Inc. | Chief Financial Officer | Buy | 15,000 | $2.58 | $38,650.50 | +4.8% | -22.9% | -14.8% | |
| Sep 13, 2022 | HCWB Hcw Biologics Inc. | Chief Financial Officer | Buy | 30,000 | $2.61 | $78,414.00 | +5.2% | -16.3% | -21.4% | |
| Aug 31, 2022 | HCWB Hcw Biologics Inc. | Chief Financial Officer | Buy | 17,200 | $2.55 | $43,913.28 | +3.2% | -16.2% | -29.5% | |
| Aug 29, 2022 | HCWB Hcw Biologics Inc. | Chief Financial Officer | Buy | 20,000 | $2.55 | $51,020.00 | +4.0% | -14.4% | -24.0% | |
| Aug 25, 2022 | HCWB Hcw Biologics Inc. | Chief Financial Officer | Buy | 90,300 | $2.54 | $229,747.08 | +25.0% | -15.9% | -22.7% | |
| Jun 14, 2022 | HCWB Hcw Biologics Inc. | Chief Financial Officer | Buy | 66,452 | $2.42 | $160,798.46 | +35.8% | -2.2% | -21.9% | |
| Aug 19, 2021 | HCWB Hcw Biologics Inc. | Chief Financial Officer | Buy | 10,000 | $4.40 | $43,979.00 | +19.2% | -31.0% | -51.5% | |
| Jul 22, 2021 | HCWB Hcw Biologics Inc. | Chief Financial Officer | Buy | 25,000 | $8.00 | $200,000.00 | +92.6% | -42.6% | -50.1% |